STUDY QUESTION: Does extended culture to the blastocyst stage affect singleton birthweight after either fresh or vitrified-warmed embryo transfer?
Introduction
Extended culture has previously been held responsible for adverse neonatal outcomes, namely a higher risk of preterm delivery and lower birthweight (Maheshwari et al., 2013; Dar et al., 2014) . However, most of these studies on culture duration and birthweight are retrospective unmatched single-centre or national register-based cohort studies. Numerous limitations in these studies may compromise their findings, including significant baseline characteristics differences between the Day 3 and Day 5 groups (Forman et al., 2013) , exceedingly low sample sizes (Mäkinen et al., 2013; Zhu et al., 2014) and inconsistent day of transfer for cleavage-stage (Day 2 vs. Day 3) and blastocysts (Day 5 vs. Day 6). Furthermore, culture medium details are mostly lacking or different culture media are used throughout the study (Mäkinen et al., 2013; Zhu et al., 2014) .
More recent studies have failed to confirm the risk of adverse neonatal outcomes related to blastocyst culture (Chambers et al., 2015; De Vos et al., 2015; Maxwell et al., 2015; Oron et al., 2015; Ginström Ernstad et al., 2016) . Moreover, culture conditions in terms of oxygen concentration have also been considered potentially responsible for any adverse outcomes (Gardner, 2016) .
Additional to the effect of extended culture, the influence of cryopreservation on obstetric and perinatal outcomes should be considered. However, in contrast to the slow-freezing method (Pinborg et al., 2014) , vitrification does not seem to have an adverse effect on neonatal outcome for either cleavage-stage embryos (Liu et al., 2013; Belva et al., 2016) or blastocysts Roy et al., 2014; Belva et al., 2016) . In view of the continuing debate about effectiveness and safety related to blastocyst transfer (Martins et al., 2016) , we aimed to further clarify this safety issue. The objective of our study was therefore, to compare the gestational age and birthweight of liveborns delivered following ART with embryo culture to either cleavage-stage or blastocyst, in both fresh and vitrifiedwarmed embryo transfer cycles.
Materials and Methods

Study design and study groups
The present analysis represents a neonatal follow-up of children included in a retrospective study comparing cumulative live birth rates between cleavage-stage and blastocyst transfers in the first treatment cycle (De Vos et al., 2016) . All patients were under 36 years of age and were scheduled for a fresh single embryo transfer, either on Day 3 (fresh cleavage-stage transfer, FCT) or on Day 5 (fresh blastocyst transfer, FBT). Supernumerary embryos or blastocysts were cryopreserved by vitrification and the consecutive frozen embryo transfers (FET) were taken into account until the birth of a first child. Patients received either a vitrified-warmed cleavage-stage transfer (VCT) or a vitrified-warmed blastocyst transfer (VBT). In FET cycles, one or two embryos were replaced. Inclusion and exclusion criteria, details on ovarian stimulation, oocyte retrieval, IVF/ICSI treatment, embryo culture and fresh embryo transfer, vitrification and preparation of the FET cycle were described previously (De Vos et al., 2016) .
There were 7 cases with missing data on singleton birthweight and 10 cases of vanishing twins which were excluded from the analysis. The present neonatal follow-up included 447 liveborn singletons born between September 2010 and August 2015. Our sample was subdivided and compared as follows: FCT Day 3 (n = 113) versus FBT Day 5 (n = 218) and VCT Day 3 (n = 58) versus VBT Day 5 (n = 58).
Ethical approval
This study was approved by the UZ Brussel ethical committee (B.U.N. 143201629894). Due to the retrospective nature of the study, written informed consent was not required.
Outcome measures
The evaluated neonatal outcome parameters were: birthweight, low birthweight (<2500 g), very low birthweight (<1500 g), gestational age (calculated from the day of oocyte retrieval, defined as Day 14 of the menstrual cycle), preterm birth (delivery before 37 weeks), very preterm birth (delivery before 32 weeks) and newborn gender. Maternal age, BMI, smoking habits, parity and infertility cause were documented at the start of the treatment cycle.
Statistical analysis
In order to determine the effect prolonged embryo culture on gestational age and birthweight following both fresh and vitrified-warmed embryo transfers, we performed multivariable linear regression accounting for the following potential confounders: maternal age, BMI, parity and current smoking habits. In the latter case, we opted to standardize birthweights using z-scores (Schisterman et al., 2009 ) in order to adequately account for the effect of gestational age and newborn gender on birthweight (Niklasson and Albertsson-Wikland, 2008) , as previously described (Belva et al., 2016) .
Results
The main maternal and treatment characteristics of the included cycles are presented in Table I (fresh transfers) and Table II (vitrified-warmed transfers). In the vitrified-warmed cycles, although the median age and the distribution of FET rank were slightly different and a trend toward a different number of transferred embryos was observed, all other characteristics were comparable between the VCT and VBT groups. The unadjusted median singleton birthweight was similar after FCT (3300 g) and FBT (3250 g; P = 0.34; Table III ). Likewise, the unadjusted median singleton birthweights did not differ after VCT (3433 g) and VBT (3240 g; P = 0.16; Table IV ). However, adjustment for gestational age and gender resulted in a significantly lower birthweight z-score in the VBT group than in the VCT group (P = 0.013; Table IV), a difference not observed in the fresh transfer groups (P = 0.32; Table III) .
Following multivariable regression analysis, the FCT and FBT groups did not show a significant difference in terms of birthweight z-scores, but the transfer of vitrified blastocysts (VBT) was associated with a lower birthweight than the transfer of vitrified cleavage-stage embryos (VCT) ( Table V) .
Discussion
The present retrospective cohort study showed no influence on birthweight associated with the use of extended culture in FBT. After vitrification, blastocyst transfer was associated with a significantly lower birthweight z-score compared to cleavage-stage transfer.
The results after FBT are reassuring and confirm our earlier findings (De Vos et al., 2015) . In contrast with two observational population-based studies (Kalra et al., 2012; Dar et al., 2013) , we did not observe an increased frequency of preterm birth associated with extended culture. The present results are in line with many other publications reporting on gestational age and birthweight after extended culture (Schwärzler et al., 2004; Martin et al., 2012; Ishihara et al., 2014; Maxwell et al., 2015) , including a study with a similar-sized cohort (Oron et al., 2015) . However, a larger future corroborating study could increase the validity of these findings (Maxwell et al., 2015) .
Adverse perinatal outcomes with blastocyst transfer have been reported solely in large observational studies (Maheshwari et al., 2013; Dar et al., 2014) , lacking proper controls for specific confounders and thus decreasing the confidence in the estimates (Martins et al., 2016) . These findings have not been confirmed in controlled studies (Maxwell et al., 2015; Oron et al., 2015) , although these do suffer from small sample sizes. This controversy will persist until conclusive evidence will be provided by adequately powered RCTs (Maheshwari et al., 2016) .
Following vitrification, blastocyst transfer was surprisingly associated with a lower birthweight z-score compared with cleavage-stage transfer. It may be considered that the use of z-scores uncovered a difference in birthweights which would have otherwise remain unnoticed in a less robust analysis (such as the direct comparison of nonstandardized birthweights), given that our sample had a skewed gender distribution in the vitrification blastocyst group (63% male offspring). The altered gender distribution may in turn be related to the small sample sizes in both vitrified-warmed study groups. Owing to the small sample size of this study, any definite conclusion on the effect of extended culture on neonatal outcomes cannot be reached until future validation is reached through larger studies. However, we would caution, regarding the feasibility of such trials, that for the fresh embryo transfer analysis, in order to obtain an 80% power to detect the ±50 g difference between the FCT and FBT groups which we found, one would require over 1800 patients (900 in each group). On the other hand, our study, although being clearly underpowered to detect such a minute difference, was sufficiently large to have 80% power to detect differences >180 g. The present data provided an adequate neonatal follow-up analysing the impact of blastocyst transfer on fresh and vitrified neonatal outcome at a time when well-designed prospective studies reporting on the presently studied outcomes are lacking. However, further prospective research should definitely be encouraged, not only for fresh but also for VBTs. In the era of a 'freeze-all' strategy (Blockeel et al., 2016) , these results will become increasingly important. 
